ArticleBMJ open respiratory research2026
How doctors present treatment options in advanced lung cancer consultations: a conversation analytic study.
Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo facilitate shared decision-making (SDM), it is important that doctors clearly present the decision to be made and the available treatment options to the patient. This study explored how treatment options after first-line therapy were presented in advanced lung cancer consultations.
methodsAudio recordings of 12 advanced lung cancer consultations between patients, their companions and doctors in three Norwegian hospitals were transcribed and analysed using Conversation Analysis. Data were collected between November 2019 and March 2022.
resultsDoctors employed three strategies when presenting treatment options to patients. These were (1) open option presentation, (2) selective option presentation and (3) recommended option presentation. Strategy (1) involved the doctor presenting all the possible treatment options in a balanced manner to the patient. With strategy (2), the doctor presented selected treatment options to the patient, and, for example, did not articulate the possibility of refraining from further therapy. Strategy (3) included the doctor's explicit preference for certain treatment options.
conclusionsStrategies that doctors employ to present treatment options to patients facilitated SDM to different degrees, where some can challenge core principles of SDM, such as creating choice awareness. Doctors must be aware of their strategies to ensure that treatment options are presented to patients in a way that supports SDM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.